The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMPLIPHI BIOSCIENCES CORP | COM NEW | 03211P202 | 620 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| AMPLIPHI BIOSCIENCES CORP | COM NEW | 03211P202 | 1,176 | 758,788 | SH | DFND | 758,788 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 44,744 | 1,176,863 | SH | SOLE | 1,176,863 | 0 | 0 | ||
| ENERGY TRANSFER EQUITY L P | COM UT LTD PTN | 29273V100 | 10,812 | 752,400 | SH | SOLE | 752,400 | 0 | 0 | ||
| ENERGY TRANSFER PRTNRS L P | UNIT LTD PARTN | 29273R109 | 3,241 | 85,135 | SH | SOLE | 85,135 | 0 | 0 | ||
| ENTERPRISE PRODS PARTNERS L | COM | 293792107 | 30,309 | 1,035,834 | SH | SOLE | 1,035,834 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM NEW | 315721209 | 11,753 | 10,219,631 | SH | SOLE | 10,219,631 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM NEW | 315721209 | 7,361 | 6,400,783 | SH | DFND | 6,400,783 | 0 | 0 | ||
| GENESIS ENERGY L P | UNIT LTD PARTN | 371927104 | 8,326 | 217,000 | SH | SOLE | 217,000 | 0 | 0 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 166,606 | 19,305,403 | SH | SOLE | 19,305,403 | 0 | 0 | ||
| HISTOGENICS CORP | COM | 43358V109 | 4,601 | 2,690,570 | SH | DFND | 2,690,570 | 0 | 0 | ||
| INTREXON CORP | COM | 46122T102 | 1,523,481 | 61,904,943 | SH | SOLE | 61,904,943 | 0 | 0 | ||
| MARTIN MIDSTREAM PRTNRS L P | UNIT L P INT | 573331105 | 3,276 | 141,800 | SH | SOLE | 141,800 | 0 | 0 | ||
| NUSTAR ENERGY LP | UNIT COM | 67058H102 | 5,802 | 116,500 | SH | SOLE | 116,500 | 0 | 0 | ||
| ORAGENICS INC | COM NEW | 684023203 | 510 | 1,000,555 | SH | SOLE | 1,000,555 | 0 | 0 | ||
| ORAGENICS INC | COM NEW | 684023203 | 7,385 | 14,481,089 | SH | DFND | 14,481,089 | 0 | 0 | ||
| OVASCIENCE INC | COM | 69014Q101 | 521 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| OVASCIENCE INC | COM | 69014Q101 | 1,423 | 273,224 | SH | DFND | 273,224 | 0 | 0 | ||
| SYNTHETIC BIOLOGICS INC | COM | 87164U102 | 17,304 | 9,613,268 | SH | DFND | 9,613,268 | 0 | 0 | ||
| SYNTHETIC BIOLOGICS INC | COM | 87164U102 | 6,525 | 3,625,000 | SH | SOLE | 3,625,000 | 0 | 0 | ||
| TC PIPELINES LP | UT COM LTD PRT | 87233Q108 | 5,554 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||
| TRANSGENOMIC INC | COM NEW | 89365K305 | 4,153 | 7,550,669 | SH | SOLE | 7,550,669 | 0 | 0 | ||
| ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 53,211 | 9,692,403 | SH | SOLE | 9,692,403 | 0 | 0 | ||